70069-0836 Bortezomib - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

70069-0836

Brand Name:

Bortezomib

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: BORTEZOMIB

Strength: 3.5

Unit: mg/3.5mL

Packages:

Code: 70069-0836-01

Description: 1 VIAL in 1 CARTON (70069-836-01) / 3.5 mL in 1 VIAL

Effective Date: April 29, 2025

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use